Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

GSK and Rgenta Therapeutics have partnered to develop RNA-targeting small molecule splice modulators for disease areas ...

Novartis will be gaining exclusive global rights to PTC Therapeutics’ mid-stage Huntington’s disease (HD) programme in a deal ...

Researchers from the Institute of Cancer Research (ICR) have found a way to predict how long prostate cancer patients will ...

Amgen has announced a $1bn investment to establish a second US drug substance manufacturing facility in North Carolina. The ...

LEO Pharma has announced that its Anzupgo (delgocitinib) cream has been approved by the Medicines and Healthcare Products ...

The challenges facing the UK’s healthcare system and why putting the patient voice at the heart of our work is key ...

Great Place To Work® and Fortune have ranked CMI Media Group and Compas as number 10 on the 2024 Fortune Best Workplaces in ...

To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business ...

Managing data effectively can be challenging in any industry. But it’s especially difficult in pharmaceuticals, which faces ...

Amgen’s investigational antibody peptide conjugate has shown promise in a mid-stage trial of patients who are overweight or ...

AstraZeneca (AZ) has appointed Iskra Reic as executive vice president, international, with the role encompassing the ...